by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
April 7, 2017 By JIM KERSTETTER For a number of years now, the federal government has been pressuring internet companies to provide information on their users. More often than not, they are obliged to cooperate by a court order — and are told to stay quiet about...
by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
WASHINGTON (Reuters) – The most senior bank examiner for Wells Fargo & Co has been removed by a U.S. regulator in the wake of the bank’s unauthorized accounts scandal, people familiar with the matter told Reuters this week.
by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
WASHINGTON (Reuters) – The most senior bank examiner for Wells Fargo & Co has been removed by a U.S. regulator in the wake of the bank’s unauthorized accounts scandal, people familiar with the matter told Reuters this week.
by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
WASHINGTON (Reuters) – The most senior bank examiner for Wells Fargo & Co has been removed by a U.S. regulator in the wake of the bank’s unauthorized accounts scandal, people familiar with the matter told Reuters this week.
by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(Reuters) – German healthcare group Fresenius SE & Co KGaA is weighing a bid for generic drugmaker Akorn Inc , Bloomberg reported on Friday, citing people familiar with the matter.
by synergycap1 | Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(Reuters) – German healthcare group Fresenius SE & Co KGaA is weighing a bid for generic drugmaker Akorn Inc , Bloomberg reported on Friday, citing people familiar with the matter.
